An Unknown Billionaire’s Big Bet on Beating Aging

Home/Financial/An Unknown Billionaire’s Big Bet on Beating Aging

An Unknown Billionaire’s Big Bet on Beating Aging

Forbes has a great profile feature by Matthew Herper on Osman Kibar and his company Samumed – an excerpt:

“Kibar, an engineering Ph.D. who emigrated from Turkey to the U.S. for college, doesn’t need to bet on cards for money. Samumed, the San Diego firm he has been stealthily building for a decade, is the most valuable biotechnology startup on the planet.

Based on investments made by private investors that include IKEA’s private venture firm, anonymous high-net-worth individuals and a single venture capital firm, Samumed has raised $220 million, and the most recent round of financing valued it at $6 billion. It is halfway through raising another $100 million at a $12 billion valuation. Kibar owns a third of the company, which would give him a net worth of $4 billion.

Samumed is finding it easy to raise huge amounts of cash because it believes it has invented medicines that can reverse aging.”

Full feature

April 13th, 2016|
X